MedTrace Logo

A Two-week Crossover Evaluation of Two Hand Antiseptic Products on Skin Condition in Healthy Human Subjects

NCT00731042 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2024-12-02

Study results available
· View outcomes & findings →

Summary

Evaluate the effect of two hand antiseptic products on hand skin conditions of healthy volunteers.

Conditions

  • Healthy

Interventions

DRUG

Avagard

Topical solution, 6 mL, 6 applications/day for 14 days.

DRUG

Purell Surgical Scrub

Topical solution, 4 mL, 6 applications/day for 14 days.

Sponsors & Collaborators

  • 3M

    collaborator INDUSTRY

  • Solventum US LLC

    lead INDUSTRY

Principal Investigators

  • Gary L Grove, PhD · cyberDERM Clinical Research

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-04-30
Completion
2008-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00731042 on ClinicalTrials.gov